Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN47055000
ISRCTN47055000
Completed
未知

A double blind randomised placebo controlled study of propolis effectiveness in the prevention and treatment of oral mucositis and in the prevention of bacteremia during oral mucositis in chemotherapy treated children

niversity Medical Centre Ljubljana (Slovenia)0 sites50 target enrollmentSeptember 7, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChemotherapy induced oral mucositisDigestive SystemOral mucositis

Overview

Phase
未知
Intervention
Not specified
Conditions
Chemotherapy induced oral mucositis
Sponsor
niversity Medical Centre Ljubljana (Slovenia)
Enrollment
50
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

  1. 2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23876561 (added 22/01/2019)
Registry
who.int
Start Date
September 7, 2012
End Date
July 1, 2013
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Medical Centre Ljubljana (Slovenia)

Eligibility Criteria

Inclusion Criteria

  • •1\. Paediatric patients, aged 1\-19 years, who had been diagnosed with cancer and had started chemotherapy
  • •2\. Informed consent

Exclusion Criteria

  • •1\. Allergy to propolis
  • •2\. Pre\-diagnosed oral disease or therapy for oral disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Double-blind, placebo-controlled randomised trial of alpha-tocopherol and oxpentifylline in patients with radiation fibrosisBreast cancerCancer
ISRCTN45257322Cancer Research UK (CRUK) (UK)
Completed
Not Applicable
Studying the impact of Lorazepam on approach/avoidance behaviour in healthy individuals
ISRCTN12590498Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)60
Completed
Not Applicable
A randomised double blinded placebo controlled trial of adrenaline in cardiac arrest
ISRCTN22893536Western Australian Prehospital Care Research Unit (Australia)2,250
Completed
Phase 2
BOSSA Study: Bosentan for the treatment of Steroid-resistant Pulmonary SarcoidosisSarcoidosis with pulmonary involvementHaematological DisordersSarcoidosis
ISRCTN73579020niversity Hospital Basel (Switzerland)36
Completed
Not Applicable
Maternal vItamin D osteoporosis studyOsteoporosisMusculoskeletal DiseasesOsteoporosis without pathological fracture
ISRCTN82927713Southampton University Hospitals NHS Trust (UK)1,074